SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BREUIL ROBERT S

(Last) (First) (Middle)
C/O CORIUM INTERNATIONAL, INC.
235 CONSTITUTION DRIVE

(Street)
MENLO PARK CA 94025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Corium International, Inc. [ CORI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/27/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/27/2018 D(1) 14,441 D $12.5(1) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $2.222 11/27/2018 D(1) 167,529 (2) 12/12/2022 Common Stock 167,529 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $4.141 11/27/2018 D(1) 17,962 (2) 01/26/2024 Common Stock 17,962 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $5.5 11/27/2018 D(1) 27,883 (2) 12/02/2024 Common Stock 27,883 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $2.222 11/27/2018 D(1) 10,688 (2) 12/12/2022 Common Stock 10,688 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $4.141 11/27/2018 D(1) 23,621 (2) 01/26/2024 Common Stock 23,621 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $5.5 11/27/2018 D(1) 55,346 (2) 12/02/2024 Common Stock 55,346 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $7.94 11/27/2018 D(1) 36,458 (3) 12/07/2025 Common Stock 36,458(2) $12.5(2) 0 D
Employee Stock Option (Right to Buy) $4.59 11/27/2018 D(1) 32,344 (2) 12/21/2026 Common Stock 32,344 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $11.59 11/27/2018 D(1) 12,031 (2) 11/30/2027 Common Stock 12,031 $12.5(2) 0 D
Employee Stock Option (Right to Buy) $7.94 11/27/2018 D(1) 12,500 (3) 12/07/2025 Common Stock 12,500 $12.5 0 D
Employee Stock Option (Right to Buy) $4.59 11/27/2018 D(1) 17,038 (3) 12/21/2026 Common Stock 17,038 $12.5 0 D
Employee Stock Option (Right to Buy) $11.59 11/27/2018 D(1) 10,573 (3) 11/30/2027 Common Stock 10,573 $12.5 0 D
Employee Stock Option (Right to Buy) $5.5 11/27/2018 D(1) 1,771 (3) 12/02/2024 Common Stock 1,771 $12.5 0 D
Employee Stock Option (Right to Buy) $7.94 11/27/2018 D(1) 1,042 (3) 12/07/2025 Common Stock 1,042 $12.5 0 D
Employee Stock Option (Right to Buy) $4.59 11/27/2018 D(1) 18,118 (3) 12/21/2026 Common Stock 18,118 $12.5 0 D
Employee Stock Option (Right to Buy) $11.59 11/27/2018 D(1) 29,896 (3) 11/30/2027 Common Stock 29,896 $12.5 0 D
Restricted Stock Units (RSU) (4) 11/27/2018 D(1) 8,437 (4) (4) Common Stock 8,437 $12.5 0 D
Restricted Stock Units (RSU) (4) 11/27/2018 D(1) 8,750 (4) (4) Common Stock 8,750 $12.5 0 D
Explanation of Responses:
1. Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the "Merger Agreement"), between Corium International, Inc. (the "Company"), Gurnet Holding Company ("Parent") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a "Share") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a "CVR").
2. Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested.
3. Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option.
4. Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU.
/s/Christina Dickerson, Attorney-in-Fact 11/28/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.